Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

SungGi Chi

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2022
[Successful treatment with gilteritinib for relapsed acute myeloid leukemia with FLT3-N676K mutation]Toru Miyajima, Shinpei Harada, Reiki Ogasawara, et al.
Cureus|September 11, 2025
A Long-Term Survival Case of Acute Myeloid Leukemia With MYC-Positive Double Minute ChromosomesRyo Yoshimaru, Ayumi Kuzume, Hirotaka Nakamura, et al.
Leukemia Research|March 25, 2026
Bi-directional association between RUNX1::RUNX1T1 and KIT mutations in acute myeloid leukemia: A multicenter genomic profiling studyYuya Arai, Seiichiro Katagiri, SungGi Chi, et al.
Cancer Science|April 29, 2026
Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in JapanSungGi Chi, Ikuko N Motoike, Takao Fujisawa, et al.
Plos Computational Biology|February 18, 2025
SpatialKNifeY (SKNY): Extending from spatial domain to surrounding area to identify microenvironment features with single-cell spatial omics dataShunsuke A Sakai, Ryosuke Nomura, Satoi Nagasawa, et al.
International Journal of Molecular Sciences|May 14, 2022
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid LeukemiaSeiichiro Katagiri, SungGi Chi, Yosuke Minami, et al.
International Journal of Hematology|December 16, 2024
A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02Hironori Arai, Naoko Hosono, SungGi Chi, et al.
Cancer Immunology Research|December 12, 2024
Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of AdministrationShunsuke A Sakai, Koichi Saeki, SungGi Chi, et al.
Blood Neoplasia|June 8, 2026
Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in JapanMinoru Kanaya, Yuji Mukai, Goichi Yoshimoto, et al.
Annals of Hematology|February 8, 2025
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 studySatoshi Iyama, SungGi Chi, Masashi Idogawa, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2022
[Successful treatment with gilteritinib for relapsed acute myeloid leukemia with FLT3-N676K mutation]Toru Miyajima, Shinpei Harada, Reiki Ogasawara, et al.
Cureus|September 11, 2025
A Long-Term Survival Case of Acute Myeloid Leukemia With MYC-Positive Double Minute ChromosomesRyo Yoshimaru, Ayumi Kuzume, Hirotaka Nakamura, et al.
Leukemia Research|March 25, 2026
Bi-directional association between RUNX1::RUNX1T1 and KIT mutations in acute myeloid leukemia: A multicenter genomic profiling studyYuya Arai, Seiichiro Katagiri, SungGi Chi, et al.
Cancer Science|April 29, 2026
Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in JapanSungGi Chi, Ikuko N Motoike, Takao Fujisawa, et al.
Plos Computational Biology|February 18, 2025
SpatialKNifeY (SKNY): Extending from spatial domain to surrounding area to identify microenvironment features with single-cell spatial omics dataShunsuke A Sakai, Ryosuke Nomura, Satoi Nagasawa, et al.
International Journal of Molecular Sciences|May 14, 2022
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid LeukemiaSeiichiro Katagiri, SungGi Chi, Yosuke Minami, et al.
International Journal of Hematology|December 16, 2024
A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02Hironori Arai, Naoko Hosono, SungGi Chi, et al.
Cancer Immunology Research|December 12, 2024
Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of AdministrationShunsuke A Sakai, Koichi Saeki, SungGi Chi, et al.
Blood Neoplasia|June 8, 2026
Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in JapanMinoru Kanaya, Yuji Mukai, Goichi Yoshimoto, et al.
Annals of Hematology|February 8, 2025
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 studySatoshi Iyama, SungGi Chi, Masashi Idogawa, et al.
Pageof 4